Abiomed
ABMD
#1371
Rank
NZ$29.15 B
Marketcap
NZ$646.51
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Earnings for Abiomed (ABMD)

Earnings in 2022 (TTM): NZ$0.55 Billion

According to Abiomed's latest financial reports the company's current earnings are NZ$1.07 Billion. In 2021 the company made an earning of NZ$0.32 Billion a decrease over its 2020 earnings that were of NZ$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Abiomed from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) NZ$0.55 B71.4%
2021 NZ$0.32 B-25.49%
2020 NZ$0.43 B-19.62%
2019 NZ$0.53 B48.14%
2018 NZ$0.36 B51%
2017 NZ$0.23 B71.85%
2016 NZ$0.13 B41.79%
2015 NZ$98.38 M187.69%
2014 NZ$34.19 M126.26%
2013 NZ$15.11 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$6.34 B 996.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
NZ$32.54 M-94.38%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$4.31 M-99.26%๐Ÿ‡บ๐Ÿ‡ธ USA